User menu

NEOPAL: A randomized phase II study comparing RCB response to neoadjuvant chemotherapy or letrozole-palbociclib in PAM50 defined postmenopausal luminal breast cancer

Bibliographic reference Cottu, Paul ; Duhoux, François ; Lemonnier, Jréôme ; Bonnefoi, Hervé ; Vincent Salomon, Anne ; et. al. NEOPAL: A randomized phase II study comparing RCB response to neoadjuvant chemotherapy or letrozole-palbociclib in PAM50 defined postmenopausal luminal breast cancer.San Antonio Breast Cancer Symposium (SABCS) (San Antonio, TX, USA, 12/12/2014). In: Cancer Research, Vol. 75, no.9, p. suppl (2015)
Permanent URL http://hdl.handle.net/2078.1/186107